National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Clinical Trials and Translational Research Advisory Committee

Presentations from the 26th Meeting Held March 4, 2015
(Presentation File Format - PDF --> Get Adobe Reader)

March 4
NIH VIDEOCAST  

WELCOME AND CHAIR UPDATE  
Chair Update
Legislative Update
Dr. Abbruzzese

NCI UPDATE  
NCI Update
Dr. Doroshow

PROPOSED PERIODIC ASSESSMENT OF THE NCI NATIONAL CLINICAL TRIALS NETWORK (NCTN) SCIENTIFIC STEERING COMMITTEE PORTFOLIOS  
Proposed Periodic Assessment of the NCI National Clinical Trials Network (NCTN) Scientific Steering Committee Portfolios
Dr. Abrams

PHASE 2 CLINICAL TRIALS COMPONENT OF THE EXPERIMENTAL THERAPEUTICS CLINICAL TRIALS NETWORK (ETCTN)  
Phase 2 Clinical Trials Component of the Experimental Therapeutics Clinical Trials Network (ETCTN)
Dr. Moscow

ADDRESSING CLINICAL TRIALS ACCRUAL CHALLENGES IN THE NCTN  
Addressing Clinical Trials Accrual Challenges in the NCTN
Ms. Denicoff

NEW BUSINESS  
New Business Dr. Abbruzzese

Top